- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 27.11. | Aclarion, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 21.11. | Aclarion, Inc.: Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash | 16 | GlobeNewswire (USA) | ||
| 14.11. | Aclarion, Inc.: Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st | 228 | ACCESSWIRE | BROOMFIELD, CO / ACCESSWIRE / November 14, 2024 / Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq:ACON)(Nasdaq:ACONW), a healthcare technology company that is leveraging biomarkers and proprietary... ► Artikel lesen | |
| 14.11. | Aclarion, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 25.10. | Aclarion, Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| 14.10. | Aclarion, Inc. droht Delisting von der Nasdaq aufgrund von Compliance-Problemen | 1 | Investing.com Deutsch | ||
| ACLARION Aktie jetzt für 0€ handeln | |||||
| 14.10. | Aclarion, Inc. faces Nasdaq delisting over compliance issues | 3 | Investing.com | ||
| 11.10. | Aclarion, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.10. | Aclarion, Inc.: Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit | 1 | GlobeNewswire (USA) | ||
| 01.10. | Aclarion, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 27.09. | Aclarion-Studie verbindet Rückenschmerzen mit MRT-nachgewiesenen Veränderungen | 1 | Investing.com Deutsch | ||
| 27.09. | Aclarion, Inc.: Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes | 2 | GlobeNewswire (USA) | ||
| 24.09. | Aclarion, Inc. startet At-the-Market-Angebot über 10 Millionen US-Dollar | 1 | Investing.com Deutsch | ||
| 24.09. | Aclarion, Inc. initiates $10 million at-the-market offering | 2 | Investing.com | ||
| 23.09. | Aclarion shareholders approve reverse stock split proposal | 2 | Investing.com | ||
| 23.09. | Aclarion-Aktionäre stimmen Vorschlag für Aktienzusammenlegung zu | 2 | Investing.com Deutsch | ||
| 23.09. | Aclarion, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.09. | Aclarion, Inc.: Aclarion Provides Corporate Update on Nociscan AI Technology Milestones | 339 | GlobeNewswire (Europe) | Successful milestones achieved and upcoming include peer-reviewed publications, commercial agreements, and payer coverage decisions Progressing with proven path toward standard of care addressing... ► Artikel lesen | |
| 10.09. | Aclarion, Inc.: Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial | 231 | GlobeNewswire (Europe) | Initial LIFEHAB Enrolled Patients Receive Nociscan Exams to Help Evaluate How Biomarkers in the Discs of the Lumbar Spine Correspond With Treatment Response LIFEHAB is a Randomized Controlled Trial... ► Artikel lesen | |
| 05.09. | Aclarion, Inc.: Aclarion Launches Surgeon Partnership to Apply Nociscan's AI Technology to Personal Injury and Workers Compensation Market | 1 | GlobeNewswire (USA) |
Seite:
1 2 Weiter >>
34 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EMEIS | 5,376 | +0,62 % | emeis announces €251m in disposals of real estate and operating assets since the beginning of October | Nearly €900 million in disposals completed since mid-2022 or secured to date Disposal of activities in Chile and the Czech Republic
Regulatory News:
emeis (Paris:EMEIS) today announced... ► Artikel lesen | |
| NANO-X IMAGING | 7,015 | 0,00 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen | |
| BUTTERFLY NETWORK | 3,085 | 0,00 % | Butterfly Network Reports Third Quarter 2024 Financial Results | BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with portable, semiconductor-based... ► Artikel lesen | |
| CARMAT | 1,022 | -3,04 % | CARMAT optimizes its financial structure by buying-back, for a symbolic sum of one euro, 2 million shares from Matra-Défense (Airbus group) which will be allocated to the repayment of its financial debt | Buy-back by CARMAT of 2 million shares from Airbus for a symbolic sum of 1 euro. The shares so bought-back will be allocated to the repayment of the Company's financial debt, via their... ► Artikel lesen | |
| GOODRX | 4,445 | 0,00 % | GoodRx Reports Third Quarter 2024 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," "GoodRx," or the "Company"), the leading prescription savings platform in the U.S., has released... ► Artikel lesen | |
| JOINT CORP | 10,100 | 0,00 % | JOINT Corp - 8-K, Current Report | ||
| TALKSPACE | 3,040 | 0,00 % | Espresa Partners with Talkspace to Boost Employee Well-Being with Accessible Mental Health Benefits | Espresa has partnered with Talkspace to expand mental health support for employees. Through Espresa's platform, clients now have access to Talkspace's 5,000+ licensed therapists, offering secure, on-demand... ► Artikel lesen | |
| MIMEDX | 9,140 | 0,00 % | MiMedx Group, Inc: MIMEDX Announces Third Quarter 2024 Operating and Financial Results | Net Sales of $84 million Grew 3% Year-Over-Year for the Third QuarterThird Quarter GAAP Net Income and Earnings Per Share were $8 Million and $0.05, RespectivelyThird Quarter Adjusted EBITDA was $18... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 83,46 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance | SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| HYPERFINE | 0,870 | 0,00 % | Hyperfine, Inc.: Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets | Strategic agreements set the stage for further global adoption of portable MR brain imaging technology, fueling expansion plans for 2025.
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health... ► Artikel lesen | |
| ATRICURE | 30,420 | 0,00 % | Pre-market Movers: ASP Isotopes, NerdWallet, Reddit, AtriCure, Qorvo | OLATHE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green ASP Isotopes Inc. (ASPI) is up over 44% at $8.33.
NerdWallet... ► Artikel lesen | |
| BIOMERICA | 0,275 | 0,00 % | BIOMERICA INC - S-8, Securities to be offered to employees in employee benefit plans | ||
| PROGYNY | 14,480 | 0,00 % | Progyny, Inc. Announces Third Quarter 2024 Results | Sales Season Yields Over 80 New Clients, 1.1 Million New Covered LivesSelected by a Leading National Health Plan and a Regional Health Plan as Their Preferred Partner1.5 Million Lives Adopt Newest... ► Artikel lesen | |
| PROPHASE LABS | 0,650 | 0,00 % | ProPhase Labs stock hits 52-week low at $0.64 amid sharp decline | ||
| AMWELL | 7,555 | 0,00 % | Amwell announces new chief financial officer | BOSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in digital care, today announced Mark Hirschhorn will become Amwell Chief Financial Officer (CFO) effective Oct. 21, succeeding... ► Artikel lesen |
Das Unternehmen ACLARION INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,128 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ACLARION INC finden Sie auf Wallstreet Online.
